DIAGNOSIS OF ENDOCRINE DISEASE The role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome
- 30 April 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 178 (5), R201-R214
- https://doi.org/10.1530/EJE-18-0007
Abstract
Desmopressin is a vasopressin analogue selective for type 2 vasopressin receptors that mediate renal water retention. In contrast to the native hormone arginine vasopressin, a well-known ACTH secretagogue, desmopressin, exerts minimal or no activity on ACTH excretion. However, in a substantial proportion of patients with ACTH-dependent Cushing's syndrome (CS), desmopressin elicits an ACTH and cortisol response, which contrasts with the minimal responses obtained in healthy subjects. The mechanism underlying this paradoxical response involves upregulation of vasopressin type 3 and/or the aberrant expression of type 2 receptors by neoplastic ACTH-producing cells. This makes desmopressin administration a suitable test enabling the distinction between neoplastic from functional (formerly termed 'pseudo-Cushing syndrome') ACTH-dependent cortisol excess. Several studies have now established an adjunctive role of desmopressin in the initial diagnostic workup of CS. Despite some early data indicating that this test may also have a role in distinguishing between Cushing's disease (CD) and ectopic ACTH secretion, subsequent studies failed to confirm this observation. The ability of the paradoxical response to desmopressin to depict the presence of neoplastic ACTH-secreting cells was also exploited in the follow-up of patients with CD undergoing surgery. Loss of the desmopressin response, performed in the early postoperative period, was a good predictor for a favorable long-term outcome. Moreover, during follow-up, reappearance of desmopressin paradoxical response was an early indicator for recurrence. In conclusion, the desmopressin test is a valid tool in both the diagnosis and follow-up of patients with CD and should be more widely applied in the workup of these patients.Keywords
This publication has 90 references indexed in Scilit:
- Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s DiseaseJournal of Clinical Endocrinology & Metabolism, 2010
- Concomitant Medication Use Can Confound Interpretation of the Combined Dexamethasone-Corticotropin Releasing Hormone Test in Cushing’s SyndromeJournal of Clinical Endocrinology & Metabolism, 2009
- The dexamethasone‐suppressed corticotropin‐releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo‐Cushing's statesClinical Endocrinology, 2007
- The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndromeClinical Endocrinology, 2000
- Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin‐releasing hormone in anorexia nervosaEuropean Journal of Clinical Investigation, 1996
- Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative resultsClinical Endocrinology, 1996
- The desmopressin stimulation test in the differential diagnosis of Cushing's syndromeClinical Endocrinology, 1993
- Corticotropin releasing factor activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressinLife Sciences, 1988
- The Corticotropin-Releasing Factor Stimulation TestThe New England Journal of Medicine, 1984
- Pituitary ACTH responsiveness in the vasopressin deficient ratLife Sciences, 1977